Abstract
74P A single-center, phase II study of surufatinib combined with toripalimab, pemetrexed(A), and platinum (P) in patients with advanced non-squamous non-small cell lung cancer (nsq-NSCLC)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have